Mihriban Tuna

Mihriban Tuna is an Entrepreneur in Residence with the Life Sciences team.

She brings 20 years of experience in biologics drug development across biotech and pharma. Prior to joining CIC, Mihriban was Chief Scientific Officer at Adaptate Biotherapeutics (acquired by Takeda Pharmaceutical Company), Senior Vice President, Drug Discovery, at F-star Therapeutics (NASDAQ: FSTX), and an early employee at Domantis Ltd. (acquired by GSK). She has authored several peer-reviewed papers and is an inventor of 15 patent families.

Mihriban holds a BSc in Biology from Middle East Technical University, a Ph.D. in Biochemistry from the University of Sussex, and an MBA from the University of Cambridge Judge Business School.